4//SEC Filing
Burke Steven Keith 4
Accession 0001562180-25-001997
CIK 0001517022other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:04 PM ET
Size
5.2 KB
Accession
0001562180-25-001997
Insider Transaction Report
Form 4
Burke Steven Keith
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2025-03-03$1.83/sh−7,144$13,074→ 809,090 total
Footnotes (2)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.
- [F2]This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001619834
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:04 PM ET
- Size
- 5.2 KB